| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.62M | 27.77M | 23.22M | 15.04M | 7.23M | 3.59M |
| Gross Profit | 5.22M | 2.30M | 1.37M | -1.94M | 206.68K | 42.17K |
| EBITDA | -48.79M | -6.54M | -7.39M | -15.63M | -7.90M | -6.48M |
| Net Income | -61.86M | -16.19M | -10.47M | -17.51M | -9.38M | -7.25M |
Balance Sheet | ||||||
| Total Assets | 19.65M | 12.18M | 5.72M | 10.60M | 22.92M | 2.81M |
| Cash, Cash Equivalents and Short-Term Investments | 653.87K | 438.30K | 226.99K | 4.19M | 16.92M | 882.87K |
| Total Debt | 27.00M | 8.21M | 6.71M | 3.56M | 476.31K | 1.55M |
| Total Liabilities | 36.92M | 10.02M | 7.62M | 4.81M | 1.06M | 4.29M |
| Stockholders Equity | -16.34M | 2.16M | -1.91M | 5.79M | 21.87M | -1.48M |
Cash Flow | ||||||
| Free Cash Flow | -20.46M | -9.84M | -6.64M | -14.86M | -8.30M | -1.63M |
| Operating Cash Flow | -15.24M | -4.59M | -6.64M | -11.60M | -6.31M | -1.61M |
| Investing Cash Flow | -2.34M | -5.93M | 2.17M | -2.43M | -5.39M | -24.07K |
| Financing Cash Flow | 16.23M | 10.72M | 2.63M | 2.53M | 24.37M | 2.48M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | $771.83M | -5.35 | -111.44% | ― | -35.99% | -46.51% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
61 Neutral | $1.99B | 18.96 | 7.64% | ― | 42.09% | 219.69% | |
50 Neutral | $35.23M | -9.92 | -54.43% | ― | -40.99% | -46.52% | |
47 Neutral | $197.58M | -0.67 | ― | ― | 146.01% | 63.18% | |
39 Underperform | $7.30M | -0.28 | -125.98% | ― | ― | ― | |
37 Underperform | $105.58M | -6.40 | -21.33% | ― | ― | 23.66% |
On November 24, 2025, NextNRG, Inc. entered into a Stock Purchase Agreement with its CEO, Michael D. Farkas, issuing 1,000,000 restricted shares at $1.04 per share. This transaction was in exchange for settling $1,040,000 of indebtedness owed to Mr. Farkas from interest accrued on promissory notes issued between June 2023 and February 2025, although the principal remains outstanding.
On November 17, 2025, NextNRG, Inc announced that its subsidiaries, NextNRG Sunnyside Microgrid LLC and NextNRG Topanga Microgrid LLC, entered into Power Purchase Agreements with Sunnyside and Topanga Nursing and Post-Acute Care Centers. These agreements involve the installation and operation of solar and battery energy systems at the facilities, with the centers agreeing to purchase the generated electricity. The contracts, which include terms for environmental incentives and early termination payments, are set for an initial term of 28 years, with potential extensions. The anticipated commercial operation dates for both projects are in late 2026, marking a significant step in NextNRG’s expansion in the renewable energy sector.
NextNRG, Inc. entered into a securities purchase agreement on September 8, 2025, with an accredited investor to sell senior secured convertible notes and warrants, which are convertible into common stock. The company conducted three closings, receiving gross proceeds of $2,500,000 each time, reflecting an 18% original issue discount on the notes. The issuance of shares related to these transactions was registered under the company’s shelf registration statement, with the third closing shares registered through a prospectus supplement.
NextNRG announced that its financial instruments, including Notes, Warrants, Due Diligence Notes, and Due Diligence Warrants, have not been registered under the Securities Act of 1933 but were offered under an exemption. However, shares of Common Stock issuable upon conversion of these instruments, issued at the Initial Closing or on October 3 and October 22, 2025, were registered pursuant to a Prospectus Supplement.
NextNRG has announced that its financial instruments, including Notes, Warrants, and shares of Common Stock, have not been registered under the Securities Act of 1933 but were offered under an exemption provided by Section 4(a)(2) and Rule 506(b). However, shares issuable upon conversion of these instruments were registered via a Prospectus Supplement, indicating a strategic move to comply with regulatory requirements while leveraging exemptions for financial maneuvering.
On September 18, 2025, NextNRG, Inc. entered into a Stock Purchase Agreement with its CEO and Executive Chairman, Michael D. Farkas. The agreement involved issuing 1,000,000 restricted shares of common stock to Farkas at $1.67 per share, which was paid by canceling $1,670,000 of the company’s debt owed to him. This private transaction did not require shareholder approval as the purchase price matched the closing bid price of the stock on the issuance date.